These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1506067)

  • 1. Dermatonecrotic lesions in rabbits caused by neuraminidase.
    Isupov IV; Sagheyeva OF; Yeliseyev YuYu ; Adamov AK; Sayapina LV; Kovalenko NM; Lukyanova OI
    Indian J Med Res; 1992 May; 95():152-6. PubMed ID: 1506067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of neuraminidase in the development of a dermonecrotic effect when Vibrio cholerae antigens are used].
    Isupov IV; Sageeva OF; Eliseev IuIu; Adamov AK; Saiapina LV; Kovalenko NM; Luk'ianova OI
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):7-11. PubMed ID: 7520652
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD; Wachsmuth IK; Feeley JC
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant effect of pertussis endotoxin protein in modulating the immune response to cholera toxoid in mice.
    Sultzer BM; Craig JP; Castagna R
    Dev Biol Stand; 1985; 61():225-32. PubMed ID: 2872108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological study of the effect of cholera toxin on germ-free animals].
    Isupov IV; Nazarova LS; Pavlova LP; Go'kova AV; Podoprigora GI
    Arkh Patol; 1981; 43(5):36-41. PubMed ID: 7283785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicological studies with therapeutically-applicable Vibrio cholerae neuraminidase.
    Ronneberger H
    Dev Biol Stand; 1977 Apr 13-15; 38():413-9. PubMed ID: 608531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.
    Pierce NF; Koster FT
    J Immunol; 1980 Jan; 124(1):307-11. PubMed ID: 6965294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1977 Jun; 16(3):789-95. PubMed ID: 892899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1989 Jul; 143(2):484-90. PubMed ID: 2544646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholera toxin and toxoid.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    Prog Immunobiol Stand; 1971; 5():348-9. PubMed ID: 4660540
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholera toxoid reactions in human volunteers: clinical and histological studies.
    Northrup RS; Chisari FV
    Prog Immunobiol Stand; 1971; 5():355-64. PubMed ID: 4660541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological bases for the resistance of the intestines to the action of cholera toxoid].
    Kalugina OP
    Arkh Anat Gistol Embriol; 1988 Mar; 94(3):69-72. PubMed ID: 3415485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
    Kay RA; Ferguson A
    Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vibrio cholerae toxin on oral immunization of chickens.
    Meinersmann RJ; Porter RE
    Avian Dis; 1993; 37(2):427-32. PubMed ID: 8363507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of gamma radiation on the immunobiological and immunochemical properties of cholera exotoxin. I. Change in the biological activity of nonpurified cholera exotoxin as affected by ionizing radiation].
    Nedugova GI; Rubtsov IV; Samoĭlenko II
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):47-51. PubMed ID: 6711194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local tolerance of muroctasin injection in rabbits.
    Nakashima K; Jindo T; Nomura M
    Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocyte response to a purified bacterial toxin (choleragen) and toxoid: cytokinetics, immunoglobulin class, and specificity.
    Kateley JR; Lyons SF; Friedman H
    J Immunol; 1974 Apr; 112(4):1452-60. PubMed ID: 4592602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.